Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis

A large number of patients with postmenopausal osteoporosis (PMO), referred to 12 Italian centers, was randomly divided into 2 groups and treated with oral IP or placebo (Pl). All patients received an oral Ca supplement (1 g/day). One hundred and twenty six patients completed 1 year of the study. Bo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone and mineral 1992-01, Vol.19, p.no. sul.-no. sul.
Hauptverfasser: Agnusdei, D, Adami, S, Cervetti, R, Crepaldi, G, Di Munno, O, Fantasia, L, Isaia, G C, Letizia, G, Ortolani, S
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!